Brief: Newron Receives Third Tranche From Financing Agreement With European Investment Bank
15/04/2020 16:52
April 15 (Reuters) - Newron Pharmaceuticals SpA NWRN.S :
* NEWRON RECEIVES THIRD TRANCHE FROM FINANCING AGREEMENT
WITH
EUROPEAN INVESTMENT BANK (EIB)
* TRANCHE 3 CONSISTS OF EUR 7.5 MILLION AND WILL PRIMARILY
BE USED
TO SUPPORT COMPANY'S DEVELOPMENT PROGRAMS IN DISEASES OF CENTRAL
NERVOUS SYSTEM
Source text for Eikon: ID:nBw4ZxkwPa
Further company coverage: NWRN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Newron Pharmaceuticals SpA
See all newsUS FDA flags four deaths in Newron's schizophrenia drug studies (updated)
US FDA cites 4 deaths in Newron's schizophrenia drug trial hold
Brief: Newron Says Topline Data From ENIGMA-TRS 1 Expected In Q1 2027
Brief: Newron Provides Update Following Type A Meeting With The FDA
Brief: Newron Reports Pause Of Enrollment Of New Study Participants In US Centers Of ENIGMA-TRS 2 Study